Top

Published in:

27-12-2023 | Glucocorticoid

Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease

Authors: E. Van Mieghem, C. De Block, C. De Herdt

Published in: Pituitary | Issue 1/2024

Abstract

Isolated adrenocorticotropic hormone deficiency (IAD) is considered to be a rare disease. Due to the nonspecific clinical presentation, precise data on the prevalence and incidence are lacking. In this systematic review, we aimed to analyse the clinical characteristics, association with autoimmune diseases, and management of acquired idiopathic IAD cases. A structured search was conducted after developing a search strategy combining terms for acquired (idiopathic) IAD. Articles describing an adult case with a diagnosis of ACTH deficiency using dynamic testing, no deficiency of other pituitary axes, and MRI of the brain/pituitary protocolled as normal, were included. Exclusion criteria were cases describing congenital IAD, cases with another aetiology for IAD, and articles where full text was not available. In total 42 articles were included, consisting of 85 cases of acquired idiopathic IAD. Distribution by sex was approximately equal (F:M; 47:38). Lethargy was the most common presenting symptom (38%), followed by weight loss (25%), anorexia (22%), and myalgia/arthralgia (12%). Eight cases (9.5%) presented with an Addison crisis. 31% of cases had an autoimmune disease at diagnosis of which Hashimoto hypothyroidism was the most frequent. Data about follow-up was scarce; dynamic testing was repeated in 4 cases of which 2 showed recovery of the adrenal axis. We report the largest case series of acquired idiopathic IAD to date. Our systematic review highlights the lack of a clear definition and diagnostic work-up. Based on the findings in this review a proposition is made for a flowchart to diagnose acquired idiopathic IAD.

Steinberg A, Shechter FR, Segal HI (1954) True pituitary addison’s disease, a pituitary unitropic deficiency; fifteen-year follow-up. J Clin Endocrinol Metab 14(12):1519–1529. https://doi.org/10.1210/jcem-14-12-1519CrossRefPubMed

Prencipe N, Marinelli L, Varaldo E, Cuboni D, Berton AM, Bioletto F et al (2023) Isolated anterior pituitary dysfunction in adulthood. Front Endocrinol (Lausanne) 14:1100007. https://doi.org/10.3389/fendo.2023.1100007CrossRefPubMed

Nowakowski KJ, Tucci JR (1989) Idiopathic isolated ACTH deficiency and the response to CRF. J Endocrinol Invest 12(4):253–255. https://doi.org/10.1007/BF03349975CrossRefPubMed

Gadelha MR, Karavitaki N, Fudin J, Bettinger JJ, Raff H, Ben-Shlomo A (2022) Opioids and pituitary function: expert opinion. Pituitary 25(1):52–63. https://doi.org/10.1007/s11102-021-01202-yCrossRefPubMed

Fujita Y, Bando H, Iguchi G, Iida K, Nishizawa H, Kanie K et al (2021) Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic hormone Deficiency. Front Endocrinol (Lausanne) 12:578802. https://doi.org/10.3389/fendo.2021.578802CrossRefPubMed

Langlois F, Varlamov EV, Fleseriu M (2022) Hypophysitis, the growing spectrum of a rare pituitary disease. J Clin Endocrinol Metab 107(1):10–28. https://doi.org/10.1210/clinem/dgab672CrossRefPubMed

Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 55(6):288–292. https://doi.org/10.1159/000050015CrossRefPubMed

Velardo A, Pantaleoni M, Zizzo G, Del Rio G, Coletta F, Carani C et al (1992) Isolated adrenocorticotropic hormone deficiency secondary to hypothalamic deficit of corticotropin releasing hormone. J Endocrinol Invest 15(1):53–57. https://doi.org/10.1007/BF03348660CrossRefPubMed

Giustina A, Romanelli G, Candrina R, Giustina G (1989) Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 68(1):120–124. https://doi.org/10.1210/jcem-68-1-120CrossRefPubMed

10.

Gotyo N, Kida M, Horiuchi T, Hirata Y (2009) Torsade De Pointes associated with recurrent ampulla cardiomyopathy in a patient with idiopathic ACTH deficiency. Endocr J 56(6):807–815. https://doi.org/10.1507/endocrj.k09e-080CrossRefPubMed

11.

Kasperlik-Zaluska AA, Czarnocka B, Czech W (2003) Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases. Autoimmunity 36(3):155–159. https://doi.org/10.1080/0891693031000095871CrossRefPubMed

12.

Ono M, Fukuda I, Nagao M, Tomiyama K, Okazaki-Hada M, Shuto Y et al (2022) HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency. Pituitary 25(4):615–621. https://doi.org/10.1007/s11102-022-01231-1CrossRefPubMed

13.

Pelewicz K, Miskiewicz P (2021) Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice. Diagnostics (Basel). https://doi.org/10.3390/diagnostics11040728CrossRefPubMed

14.

Gadelha MR, Wildemberg LE, Shimon I (2022) Pituitary acting Drugs: cabergoline and pasireotide. Pituitary 25(5):722–725. https://doi.org/10.1007/s11102-022-01238-8CrossRefPubMed

15.

Donegan D, Bancos I (2018) Opioid-induced adrenal insufficiency. Mayo Clin Proc. 93(7):937–944CrossRefPubMed

16.

Debono M, Chan S, Rolfe C, Jones TH (2011) Tramadol-induced adrenal insufficiency. Eur J Clin Pharmacol 67(8):865–867. https://doi.org/10.1007/s00228-011-0992-9CrossRefPubMed

17.

Mick I, Spring K, Uhr M, Zimmermann US (2013) Alcohol administration attenuates hypothalamic-pituitary-adrenal (HPA) activity in healthy men at low genetic risk for Alcoholism, but not in high-risk subjects. Addict Biol 18(5):863–871. https://doi.org/10.1111/j.1369-1600.2011.00420.xCrossRefPubMed

18.

Skowronska-Jozwiak E, Orzechowski S, Pietak W, Lewinski A (2022) Rare clinical problem - isolated ACTH deficiency associated with chronic alcohol abuse. Endokrynol Pol 73(4):778–783. https://doi.org/10.5603/EP.a2022.0056CrossRefPubMed

19.

Kearney T, Robinson S, Johnston DG (2000) Isolated corticotropin deficiency in chronic Alcoholism. J R Soc Med 93(1):15–17. https://doi.org/10.1177/014107680009300105CrossRefPubMedPubMedCentral

20.

Baba S, Takase S, Uenoyama R, Morita S, Mizoi Y, Hishida S (1976) Isolated corticotrophin-deficiency found through alcohol-induced hypoglycemic coma. Horm Metab Res 8(4):274–278. https://doi.org/10.1055/s-0028-1093634CrossRefPubMed

21.

Gilis-Januszewska A, Kluczynski L, Hubalewska-Dydejczyk A (2020) Traumatic brain injuries induced pituitary dysfunction: a call for algorithms. Endocr Connect 9(5):R112–R23. https://doi.org/10.1530/EC-20-0117CrossRefPubMedPubMedCentral

22.

Hannon AM, Hunter S, Smith D, Sherlock M, O’Halloran D, Thompson CJ et al (2018) Clinical features and autoimmune associations in patients presenting with idiopathic isolated ACTH deficiency. Clin Endocrinol (Oxf) 88(3):491–497. https://doi.org/10.1111/cen.13536CrossRefPubMed

23.

Yamamoto M, Iguchi G, Bando H, Kanie K, Hidaka-Takeno R, Fukuoka H et al (2020) Autoimmune pituitary disease: new concepts with clinical implications. Endocr Rev. https://doi.org/10.1210/endrev/bnz003CrossRefPubMed

24.

Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H (2022) Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: a systematic review and meta-analysis. Front Public Health 10:1020709. https://doi.org/10.3389/fpubh.2022.1020709CrossRefPubMedPubMedCentral

25.

Iwama S, Arima H (2020) Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands. Endocr J 67(11):1077–1083. https://doi.org/10.1507/endocrj.EJ20-0436CrossRefPubMed

26.

Richtsmeier AJ, Henry RA, Bloodworth JM Jr., Ehrlich EN (1980) Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med 140(9):1243–1245CrossRefPubMed

27.

Kubo N, Itokazu N, Inoue S (1997) [A case of isolated ACTH deficiency with neuromuscular symptoms]. No To Hattatsu 29(1):67–72PubMed

28.

Mori T, Murakami Y, Nishiki M, Koshimura K, Sasano H, Kato Y (2003) Expression of hypothalamic corticotropin-releasing hormone-like immunoreactivity in isolated ACTH deficiency: a report of an autopsied case. J Endocrinol Invest 26(6):556–559. https://doi.org/10.1007/BF03345220CrossRefPubMed

29.

Takahashi Y (2023) Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome. Endocr J 70(6):559–565. https://doi.org/10.1507/endocrj.EJ23-0050CrossRefPubMed

30.

Bando H, Iguchi G, Kanie K, Nishizawa H, Matsumoto R, Fujita Y et al (2018) Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome. Pituitary 21(5):480–489. https://doi.org/10.1007/s11102-018-0901-7CrossRefPubMed

31.

Yuen KCJ, Johannsson G, Ho KKY, Miller BS, Bergada I, Rogol AD (2023) Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr Connections 12(7):e220504. https://doi.org/10.1530/ec-22-0504CrossRef

32.

Kamiya Y, Murakami M (2009) Type 2 Diabetes Mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer. Intern Med 48(12):1031–1035. https://doi.org/10.2169/internalmedicine.48.1972CrossRefPubMed

33.

Kinoshita J, Higashino S, Fushida S, Oyama K, Watanabe T, Okamoto K et al (2014) Isolated adrenocorticotropic hormone deficiency development during chemotherapy for gastric cancer: a case report. J Med Case Rep 8:90. https://doi.org/10.1186/1752-1947-8-90CrossRefPubMedPubMedCentral

34.

Harano Y, Kitano A, Akiyama Y, Kotajima L, Honda K, Arioka H (2015) A case of isolated adrenocorticotropic hormone deficiency: a rare but possible cause of hypercalcemia. Int Med Case Rep J 8:77–79. https://doi.org/10.2147/IMCRJ.S63778CrossRefPubMedPubMedCentral

35.

Syriou V, Moisidis A, Tamouridis N, Alexandraki KI, Anapliotou M (2008) Isolated adrenocorticotropin deficiency and flexion contractures syndrome. Horm (Athens) 7(4):320–324. https://doi.org/10.14310/horm.2002.1213CrossRef

36.

Yamaguchi H, Nakamura H, Mamiya Y, Yamamoto Y, Tajika K, Sugihara H et al (1997) Acute lymphoblastic Leukemia with isolated adrenocorticotropic hormone deficiency. Intern Med 36(11):819–821. https://doi.org/10.2169/internalmedicine.36.819CrossRefPubMed

37.

Tanaka T, Terada N, Fujikawa Y, Fujimoto T (2016) Treatable Bedridden Elderly -Recovery from Flexion Contracture after Cortisol Replacement in a patient with isolated adrenocorticotropic hormone Deficiency. Intern Med 55(20):2975–2978. https://doi.org/10.2169/internalmedicine.55.6932CrossRefPubMedPubMedCentral

38.

Kwon MK, Kim J, Ahn J, Woo CY, Kim H, Oh HS et al (2022) Clinical features and risk factors of adrenal insufficiency in patients with Cancer admitted to the Hospitalist-Managed Medical Unit. J Korean Med Sci 37(28):e222. https://doi.org/10.3346/jkms.2022.37.e222CrossRefPubMedPubMedCentral

39.

Han HS, Park JC, Park SY, Lee KT, Bae SB, Kim HJ et al (2015) A prospective Multicenter Study evaluating secondary adrenal suppression after antiemetic dexamethasone therapy in Cancer patients receiving chemotherapy: a Korean South West Oncology Group Study. Oncologist 20(12):1432–1439. https://doi.org/10.1634/theoncologist.2015-0211CrossRefPubMedPubMedCentral

40.

Bando H, Kanie K, Takahashi Y (2022) Paraneoplastic autoimmune hypophysitis: an emerging concept. Best Pract Res Clin Endocrinol Metab 36(3):101601. https://doi.org/10.1016/j.beem.2021.101601CrossRefPubMed

41.

Alsaleem M, Saadeh L, Misra A, Madani S (2016) Neonatal isolated ACTH deficiency (IAD): a potentially life-threatening but treatable cause of neonatal cholestasis. BMJ Case Rep. https://doi.org/10.1136/bcr-2016-215032CrossRefPubMedPubMedCentral

42.

Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G et al (2005) An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 90(8):4880–4887. https://doi.org/10.1210/jc.2005-0119CrossRefPubMed

43.

Chiloiro S, Giampietro A, Bianchi A, Tartaglione T, Capobianco A, Anile C et al (2017) Diagnosis of endocrine disease: primary empty sella: a comprehensive review. Eur J Endocrinol 177(6):R275–R85. https://doi.org/10.1530/EJE-17-0505CrossRefPubMed

44.

Gallardo E, Schachter D, Caceres E, Becker P, Colin E, Martinez C et al (1992) The empty sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances. Clin Endocrinol (Oxf) 37(6):529–533. https://doi.org/10.1111/j.1365-2265.1992.tb01484.xCrossRefPubMed

45.

Matabang MA, Sapang B (2020) Primary partial empty Sella presenting with Prepubertal Hypogonadotropic Hypogonadism: a Case Report. J ASEAN Fed Endocr Soc 35(2):215–219. https://doi.org/10.15605/jafes.035.02.11CrossRefPubMedPubMedCentral

46.

Kyritsi EM, Hasiotou M, Kanaka-Gantenbein C (2020) Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1. Endocrine 69(2):377–385. https://doi.org/10.1007/s12020-020-02351-zCrossRefPubMed

47.

Guo Q, Lu J, Mu Y, Chen K, Pan C (2013) Adult idiopathic isolated ACTH deficiency: a short series and literature review. Neuro Endocrinol Lett 34(7):693–700PubMed

48.

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism 101(11):3888–3921. https://doi.org/10.1210/jc.2016-2118CrossRef

49.

Crowley RK, Argese N, Tomlinson JW, Stewart PM (2014) Central Hypoadrenalism. J Clin Endocrinol Metabolism 99(11):4027–4036. https://doi.org/10.1210/jc.2014-2476CrossRef

50.

Grossman AB (2010) Clinical Review#: the diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 95(11):4855–4863. https://doi.org/10.1210/jc.2010-0982CrossRefPubMed

51.

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101(11):3888–3921. https://doi.org/10.1210/jc.2016-2118CrossRefPubMed

52.

Kim SY (2015) Diagnosis and treatment of Hypopituitarism. Endocrinol Metab (Seoul) 30(4):443–455. https://doi.org/10.3803/EnM.2015.30.4.443CrossRefPubMed

53.

Fatani TH (2023) Diagnostic value of IGF-1 in growth hormone-deficient children: is a second growth hormone stimulation test necessary? J Endocr Soc 7(4):bvad018. https://doi.org/10.1210/jendso/bvad018CrossRefPubMedPubMedCentral

54.

Garrahy A, Agha A (2016) How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism? BMC Endocr Disord 16(1):36. https://doi.org/10.1186/s12902-016-0117-7CrossRefPubMedPubMedCentral

55.

Falb V, Costanzo L, Avalos C, Feoktistov A (2022) Autoimmune Encephalopathy Associated with anti-thyroid antibodies: a Case Report. Cureus 14(8):e28183. https://doi.org/10.7759/cureus.28183CrossRefPubMedPubMedCentral

56.

Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB et al (2018) The short Synacthen (Corticotropin) Test can be used to predict recovery of hypothalamo-pituitary-adrenal Axis function. J Clin Endocrinol Metab 103(8):3050–3059. https://doi.org/10.1210/jc.2018-00529CrossRefPubMed

Title: Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease
Authors: E. Van Mieghem
C. De Block
C. De Herdt
Publication date: 27-12-2023
Publisher: Springer US
Keyword: Glucocorticoid
Published in: Pituitary / Issue 1/2024
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-023-01366-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2024

Newer parameters of the octreotide test in patients with acromegaly

Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency

Pituitary apoplexy score, toward standardized decision-making: a descriptive study

Consensus on criteria for acromegaly diagnosis and remission

Pituitary: hic manebimus optime

Correction: incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials